Lymphoma Clinical Trials

Showing 1061-1080 of 3,379 trials

MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy

NCT05333367

The objective of this study is to describe the type of cell death induced by extracorporeal photochemotherapy, depending on the cell type, using a panel of complementary analysis techniques.

Cutaneous T-Cell LymphomaGraft Vs Host DiseaseGraft Rejection

Centre Hospitalier Universitaire de Besancon20 participantsStarted Apr 2022

Besançon, France

RECRUITING

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

NCT06116110

This is an observational long-term follow-up (LTFU) study for subjects who previously received zamtocabtagene autoleucel, known as MB-CART2019.1.

Non Hodgkin Lymphoma

Miltenyi Biomedicine GmbH150 participantsStarted May 2024

Stanford, California, United States • New Haven, Connecticut, United States • Baltimore, Maryland, United States +2 more locations

Enrolling By Invitation

A Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007

NCT05509855

This study will provide long-term follow-up for patients who have received treatment with WU-CART-007 in a previous clinical trial. In this study, patients will be followed for up to 15 years after their last dose of WU-CART-007 for evaluation of delayed adverse events, presence of persisting WU-CART-007 vector sequences, and overall survival and progression-free survival.

T-cell Acute Lymphoblastic LeukemiaT-cell Lymphoblastic Lymphoma

Wugen, Inc.44 participantsStarted Aug 2022

Duarte, California, United States • Los Angeles, California, United States • St Louis, Missouri, United States +2 more locations

MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

A Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007

Related Searches

A Study to Learn About the Study Medicine (Maplirpacept) in People With Advanced Non-Hodgkin Lymphoma or Multiple Myeloma in China

Study to Evaluate the Safety and Preliminary Efficacy of Ibrutinib and Pembrolizumab in Patients With Chronic Lymphocytic Leukemia (CLL) or Mantle Cell Lymphoma (MCL)

Phase I Clinical Trial of Autologous CD7-CAR T Cell Therapy for High-risk Acute T-cell Leukemia/lymphoma

A Prospective Clinical Study of the Combination Therapy of Obutinib or Decitabine with Rituximab, Cyclophosphamide, and Prednisone for the Primary Treatment of Elderly Patients with Newly Diagnosed Diffuse Large B-cell Lymphoma

Optimizing Lymphodepletion to Improve Outcomes in Patients Receiving Cell Therapy With Kymriah

The In4M Study: Integrating 4 Methods to Assess Physical Function in Cancer Patients

MargheRITA (Remote Intelligence for Therapeutic Adherence)

A Study to Learn About the Study Medicine (Called Maplirpacept (PF-07901801)) in Japanese With Hematologic Malignancies

Pralatrexate Combined With Chidamide Bridging Allogeneic HSCT for Refractory/Relapsed Peripheral T-cell Lymphoma

Phase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL)

Quest to Analyze One Thousand Humans Meditating

A Dose Escalation and Expansion Study of ASP4132 to Subjects With Advanced Refractory Tumors and Lymphoma

KSD-101 Therapy for EBV-associated Lymphomas: an Exploratory Clinical Trial

Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-087/KEYNOTE-087)

Oral Azacitidine Plus Salvage Chemotherapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma

BTK Inhibitor BGB-3111 in Chinese Participants With Diffuse Large B-Cell Lymphoma (Non-GCB) and Indolent Lymphoma (FL and MZL)

Study of Zanubrutinib (BGB-3111) in Participants With Marginal Zone Lymphoma